topic

1456 Colorectal cancer disparities: a systematic review
Fnu Anamika, Akshit Chitkara, Victoria Gutierrez, Kavvya Gupta, Bhuvaneswari Ramaswamy

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1619; DOI: 10.1136/jitc-2023-SITC2023.1456
1457 Visium HD enables spatially resolved, single-cell scale resolution mapping of FFPE human breast cancer tissue
Monica Nagendran, Jerald Sapida, Joey Arthur, Yifeng Yin, Sultan Doganay Tuncer, Naishita Anaparthy, Anushka Gupta, Marco Serra, David Patterson, Augusto Tentori

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1620; DOI: 10.1136/jitc-2023-SITC2023.1457
1458 TTLL8, POTEE, and PKMYT1 are targetable tumor antigens in ovarian cancer
Esen Yonca Bassoy, Remya Raja, Tom Rubino, Fabian Coscia, Krista Goergen, Brenda Ernst, Paul Magtibay, Kristina Butler, Alessandra Schmitt, Ann Oberg, Marion Curtis

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1621; DOI: 10.1136/jitc-2023-SITC2023.1458
1459 Association with stemness and functional role of immunoreceptor NKG2D expression in acute myeloid leukemia
Ilona Hagelstein, Sylwia A Stefanczyk, Kim L Clar, Kathrin Rothfelder, Jonas Rieth, Jonas S Heitmann, Helmut R Salih

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1622; DOI: 10.1136/jitc-2023-SITC2023.1459
1460 PP2Ac deficiency enhances tumor immunogenicity by activating STING-Type I interferon signaling in glioblastoma
Winson Ho, Isha Mondal, Beisi Xu, Rongze Lu

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1623; DOI: 10.1136/jitc-2023-SITC2023.1460
1461 Induction of clonal expansion of tumor-reactive T cells and effective tumor suppression by neoantigens predicted from the ‘VACINUS‘ platform
Sang Hoon Kim, Sung-Min Kim, Kyuyoung Song, Woongyang Park

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1624; DOI: 10.1136/jitc-2023-SITC2023.1461
1462 Antibodies specifically recognizing cancer-associated glycoforms of mucin-like proteins
Theresa Neumann, Evelyn Hartung, Timo Lischke, Naomi Kast, Lisa Weiss, Luisa Willmann, Stephanie Gurka, Sophie Marinoff, Johanna Gellert, Sven Barke, Antje Danielczyk, Patrik Kehler

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1625; DOI: 10.1136/jitc-2023-SITC2023.1462
1463 The intra-tumoral spatial heterogeneity of T cell antigens in glioblastoma: An integrated multi-omics approach
Marcel Wacker, Gioele Medici, Marissa Dubbelaar, Jens Bauer, Annika Nelde, Friederike Hanssen, Carolin Schwitalla, Luca Regli, Michael Weller, Hans-Georg Rammensee, Marian Christoph Neidert, Juliane S Walz

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1626; DOI: 10.1136/jitc-2023-SITC2023.1463
1464 Endogenous retroviral protein particles in malignant pleural mesothelioma as potential immunotherapy targets; novel approaches for identification and prioritization
Amin Zia, Licun Wu, Zhihong Yun, Fatemeh Zaeimi, Marc de Perrot

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1627; DOI: 10.1136/jitc-2023-SITC2023.1464
1465 Multiplex imaging identifies unique immunophenotypic and spatial characteristics associated with response to immune checkpoint inhibitors (ICIs) in metastatic urothelial cancer (mUC)
Jonathan Anker, John-William Sidhom, Guray Akturk, Sudeh Izadmehr, Justin David, Saurabh Gupta, Seunghee Kim-Schulze, Padmanee Sharma, Sacha Gnjatic, Matthew Galsky

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A1628-A1629; DOI: 10.1136/jitc-2023-SITC2023.1465

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages